Genetic diversity of the apolipoprotein E gene and diabetic nephropathy: A meta-analysis

Molecular Biology Reports

Volumn 38, Issue 5, 2011, Pages 3243-3252

  Li, Yang ^a,b   Tang, Kefu ^a,b   Zhang, Zhao ^a,b   Zhang, Ming ^a,b   Zeng, Zhen ^a,b   He, Zangdong ^a,b   He, Lin ^a,b,c   Wan, Chunling ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

^c FUDAN UNIVERSITY   (China)

Author keywords

Apolipoprotein E; Diabetic nephropathy; Genetic polymorphism; Meta analysis

Indexed keywords

APOLIPOPROTEIN E2; APOLIPOPROTEIN E2 EPSILON; APOLIPOPROTEIN E4; APOLIPOPROTEIN E4 EPSILON; UNCLASSIFIED DRUG;

ALLELE; APOLIPOPROTEIN E GENE; ARTICLE; ASIAN; DIABETIC NEPHROPATHY; DIABETIC PATIENT; DISEASE DURATION; ETHNIC DIFFERENCE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FAILURE; MACROALBUMINURIA; META ANALYSIS; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEINURIA; RISK FACTOR;

ALLELES; APOLIPOPROTEINS E; DIABETIC NEPHROPATHIES; GENETIC VARIATION; GENOTYPE; HUMANS; POLYMORPHISM, GENETIC; PUBMED;

EID: 79958145264     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-010-9999-z     Document Type: Article

References (46)

1. Gross JL et al (2005) Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care 28(1):164-176 (Pubitemid 40095801)
2. Rippin JD, Patel A, Bain SC (2001) Genetics of diabetic nephropathy. Best Pract Res Clin Endocrinol Metab 15(3):345-358 (Pubitemid 32916266)
3. Kimura H et al (1998) Apolipoprotein E4 reduces risk of diabetic nephropathy in patients with NIDDM. Am J Kidney Dis 31(4): 666-673 (Pubitemid 28158008)
4. Chowdhury TA et al (1999) Genetic determinants of diabetic nephropathy. Clin Sci (Lond) 96(3):221-230 (Pubitemid 29129172)
5. Joss N et al (2005) Influence of apolipoprotein E genotype on progression of diabetic nephropathy. Nephron Exp Nephrol 101(4): e127-e133
6. Quinn M et al (1996) Familial factors determine the development of diabetic nephropathy in patients with IDDM. Diabetologia 39(8):940-945 (Pubitemid 26249113)
7. Ravid M et al (1998) Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia. Arch Intern Med 158(9):998-1004 (Pubitemid 28213577)
8. Ha SK et al (1999) Association between apolipoprotein E polymorphism and macroalbuminuria in patients with non-insulin dependent diabetes mellitus. Nephrol Dial Transplant 14(9): 2144-2149
9. Jandeleit-Dahm K et al (1999) Role of hyperlipidemia in progressive renal disease: focus on diabetic nephropathy. Kidney Int Suppl 71:S31-S36 (Pubitemid 29304809)
10. Lam KS et al (1995) Cholesterol-lowering therapy may retard the progression of diabetic nephropathy. Diabetologia 38(5):604-609
11. Eto M et al (2002) Apolipoprotein E genetic polymorphism, remnant lipoproteins, and nephropathy in type 2 diabetic patients. Am J Kidney Dis 40(2):243-251 (Pubitemid 34827641)
12. Park JS et al (2004) Apolipoprotein E genetic polymorphism and diabetic microangiopathy in type 2 diabetic patients. J Korean Diab Assoc 28:511-520
13. Krieger M, Herz J (1994) Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP). Annu Rev Biochem 63:601-637
14. Mahley RW (1988) Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240(4852):622-630
15. Ha TS et al (2004) Regulation of glomerular endothelial cell proteoglycans by glucose. J Korean Med Sci 19(2):245-252
16. Moorhead JF et al (1982) Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease. Lancet 2(8311):1309-1311 (Pubitemid 13240921)
17. Diamond JR (1991) Analogous pathobiologic mechanisms in glomerulosclerosis and atherosclerosis. Kidney Int Suppl 31:S29-S34
18. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177-188 (Pubitemid 17189972)
19. Zintzaras E, Hadjigeorgiou GM (2004) Association of paraoxonase 1 gene polymorphisms with risk of Parkinson's disease: a meta-analysis. J Hum Genet 49(9):474-481 (Pubitemid 39314366)
20. Woolf B (1955) On estimating the relation between blood group and disease. Ann Hum Genet 19(4):251-253
21. Egger M et al (1997) Bias in meta-analysis detected by a simple, graphical test. Bmj 315(7109):629-634 (Pubitemid 27387172)
22. Horita K, Eto M, Makino I (1994) Apolipoprotein E2, renal failure and lipid abnormalities in non-insulin-dependent diabetes mellitus. Atherosclerosis 107(2):203-211 (Pubitemid 24206859)
23. Onuma T et al (1996) Apolipoprotein E genotypes and risk of diabetic nephropathy. J Am Soc Nephrol 7(7):1075-1078 (Pubitemid 27465972)
24. Chowdhury TA et al (1998) Association of apolipoprotein epsilon2 allele with diabetic nephropathy in Caucasian subjects with IDDM. Diabetes 47(2):278-280
25. Tarnow L et al (2000) Plasminogen activator inhibitor-1 and apolipoprotein E gene polymorphisms and diabetic angiopathy. Nephrol Dial Transplant 15(5):625-630 (Pubitemid 30242979)
26. Hadjadj S et al (2000) Lack of relationship in long-term type 1 diabetic patients between diabetic nephropathy and polymorphisms in apolipoprotein epsilon, lipoprotein lipase and cholesteryl ester transfer protein. Genetique de la Nephropathie Diabetique Study Group. Donnees Epidemiologiques sur le Syndrome d'Insulino-Resistance Study Group. Nephrol Dial Transplant 15(12):1971-1976
27. Araki S et al (2000) APOE polymorphisms and the development of diabetic nephropathy in type 1 diabetes: results of case-control and family-based studies. Diabetes 49(12):2190-2195
28. Shcherbak NS (2001) Apolipoprotein E gene polymorphism is not a strong risk factor for diabetic nephropathy and retinopathy in Type I diabetes: case-control study. BMC Med Genet 2:8
29. Akarsu E, Purum Ü (2001) A relation between the apolipoprotein E genotypes and microalbuminuria in type 2 diabetes mellitus. Turk J Med Sci 31:59-64
30. Orchard TJ et al (2002) Nephropathy in type 1 diabetes: a manifestation of insulin resistance and multiple genetic susceptibilities? Further evidence from the Pittsburgh Epidemiology of Diabetes Complication Study. Kidney Int 62(3):963-970 (Pubitemid 35316726)
31. Hsieh MC et al (2002) Higher frequency of apolipoprotein E2 allele in type 2 diabetic patients with nephropathy in Taiwan. J Nephrol 15(4):368-373
32. Araki S et al (2003) APOE polymorphism and the progression of diabetic nephropathy in Japanese subjects with type 2 diabetes: results of a prospective observational follow-up study. Diabetes Care 26(8):2416-2420 (Pubitemid 36993336)
33. Liu L et al (2003) Co-inheritance of specific genotypes of HSPG and ApoE gene increases risk of type 2 diabetic nephropathy. Mol Cell Biochem 254(1-2):353-358 (Pubitemid 37483772)
34. Ng MC et al (2006) Association of lipoprotein lipase S447X, apolipoprotein E exon 4, and apoC3-455T[C polymorphisms on the susceptibility to diabetic nephropathy. Clin Genet 70(1):20-28 (Pubitemid 44192730)
35. Leiva E et al (2007) Relationship between Apolipoprotein E polymorphism and nephropathy in type-2 diabetic patients. Diabetes Res Clin Pract 78(2):196-201 (Pubitemid 47451528)
36. Kwon MK et al (2007) Association between apolipoprotein E genetic polymorphism and the development of diabetic nephropathy in type 2 diabetic patients. Diabetes Res Clin Pract 77(Suppl 1):S228-S232
37. Ilhan N et al (2007) Apo E gene polymorphism on development of diabetic nephropathy. Cell Biochem Funct 25(5):527-532 (Pubitemid 47436093)
38. Ma SW, Benzie IF, Yeung VT (2008) Type 2 diabetes mellitus and its renal complications in relation to apolipoprotein E gene polymorphism. Transl Res 152(3):134-142
39. Guan J et al (2009) Apolipoprotein E polymorphism and expression in type 2 diabetic patients with nephropathy: clinicopathological correlation. Nephrol Dial Transplant 24(6):1889-1895
40. Erdogan M et al (2009) The relationship of the apolipoprotein E gene polymorphismin Turkish Type 2 diabetic patients with and without nephropathy. J Endocrinol Invest 32(3):219-222
41. Eto M et al (1995) Increased frequency of apolipoprotein epsilon 2 allele in non-insulin dependent diabetic (NIDDM) patients with nephropathy. Clin Genet 48(6):288-292 (Pubitemid 26039097)
42. Xu MQ, St Clair D, He L (2006) Meta-analysis of association between ApoE epsilon4 allele and schizophrenia. Schizophr Res 84(2-3):228-235
43. Liberopoulos E, Siamopoulos K, Elisaf M (2004) Apolipoprotein E and renal disease. Am J Kidney Dis 43(2):223-233 (Pubitemid 38146320)
44. Sato H et al (1991) Immunohistological localization of apolipoproteins in the glomeruli in renal disease: specifically apoB and apoE. Clin Nephrol 36(3):127-133
45. Bruneval P et al (2002) Mesangial expansion associated with glomerular endothelial cell activation and macrophage recruitment is developing in hyperlipidaemic apoE null mice. Nephrol Dial Transplant 17(12):2099-2107 (Pubitemid 35446664)
46. Chen G et al (2001) A protective role for kidney apolipoprotein E. Regulation of mesangial cell proliferation and matrix expansion. J Biol Chem 276(52):49142-49147